NCT01079884View on ClinicalTrials.gov

Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
GERD
Interventions
DRUG

esomeprazole 40 mg

40 mg daily for 4 weeks

Trial Locations (1)

23502

Digestive and Liver Disease Specialists, Norfolk

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

David A. Johnson, MD

OTHER